Lansoloc 30mg Capsules
PDF Leaflet Revision Date: 03 February 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Short-term treatment of gastric and duodenal ulcers and reflux oesophagitis.
Dosage (summary)
30 mg once daily before meals; max 30 mg/day for elderly.
Onset of Action / Duration
Onset: 30 mins, Duration: 24 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- Fluvoxamine
- Warfarin
- Methotrexate
- Tacrolimus
- Atazanavir
Contraindications
- Hypersensitivity to lansoprazole
- Pregnancy
- Liver impairment
Common side effects
- Headache
- Dizziness
- Fatigue
- Nausea
- Diarrhoea
Counselling Points
- Take before meals
- Monitor magnesium levels
- Avoid alcohol and CNS depressants
Serious warnings
- Risk of hypomagnesaemia
- Increased risk of fractures
- Possible malignancy in gastric ulcers
Important Disclaimer
The Lansoloc 30mg Capsules professional information leaflet below is the property of Cipla Medpro _Old and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
